Canada's shift on tamper resistant opioids a bitter pill for U.S. coalitionHealth Canada criticized for failing to enact strict new regulations. PPIs linked to increased risk of chronic kidney disease and progression to end-stage renal diseaseRisk of adverse renal outcomes increases with duration of PPI use beyond 30 days. Skin test poor predictor of amoxicillin allergy, McGill researchers find New report reveals inequities in people's health risks, care and outcomes based on their income Endocrine Society takes strong stance against custom-compounded bioidentical hormone products No rationale for routine prescribing of these unregulated, untested, potentially harmful products. N.S. health minister calls for review of prescription drug monitoring program Call follows charges against doctor who allegedly sold more than 50,000 Oxycodone and other prescription narcotics. Pharmacy innovation: two steps forward, one step back Speakers shared ground-breaking research and cautionary advice in equal measure at the Canadian Foundation for Pharmacy’s Innovation Gala dinner in Toronto last week Largest study of its kind shows benefits of Medtronic insulin pumps for people with type 2 diabetes ASA use for the primary prevention of cardiovascular disease and colorectal cancer US task force issues updated recommendations that balance benefits and harms. UK pharmacy chain accused of abusing med review program Media reports allege Boots uses quotas to pressure pharmacists into conducting unneeded medication reviews. First Previous 667 668 669 670 671 Next Last
